| Johnson & Johnson today [Feb 27] announced that the U.S. Food and Drug Administration [FDA] has issued Emergency Use Authorization for its single-dose Covid-19 vaccine. “This decision was based on the totality of scientific evidence, including data from the Phase 3 ENSEMBLE study that demonstrated the vaccine was 85 percent effective in preventing severe disease […]
|